發表時間： 2022-05-16 15:04:30
世界農化網中文網報道：在近來舉行的印度中央殺蟲劑理事會及登記委員會（CIBRC）第439次會議上，該機構根據u/s 9(3)授予Indogulf Cropsciences Limited阿維菌素原藥進口許可證。獲準進口的原藥由阿維菌素主要生產商河北興柏藥業集團生產。我集團擁有阿維菌素的專有生產工藝和提取技術，是中國一家以玉米為原料生產阿維菌素的企業。
Indogulf Cropsciences Ltd是農化品、作物養分、原藥和制劑的領先制造商和出口商。該公司組建了覆蓋印度國內市場的分銷網絡，并將產品出口到亞洲、非洲、拉丁美洲和中東地區。
Xingbai Group supports Indogulf Cropsciences to get registration for the Import of Abamectin Technical in India
Indogulf Cropsciences Limited has informed that the Company has been granted Licence for import of Abamectin Technical u/s 9(3) by Central Insecticides Board & Registration Committee' in its 439th recent meeting. The approved source Hebei Xingbai Agricultural Technology Co., Ltd., is the fundamental producer of Abamectin. Xingbai Group owns a proprietary production process and extraction technology of abamectin. Xingbai Group is the only firm in China that produces avermectin with corn as raw material from the very beginning. Reported by AGROPAGES.
As a macrolide antibiotic, Abamectin has a unique mechanism of action. It can simultaneously target multiple targets inside bodies of pests such as nematodes and arthropods which damage the agricultural crops, paralyze and kill such pests by blocking nerve signal transmission. Abamectin being a top molecule has enormous demand in the domestic and global markets of North America, Europe, Asia-Pacific, South America Middle East, and Africa. The Global Abamectin market is anticipated to rise at a considerable rate, between 2022 and 2028. The market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Indogulf Cropsciences Ltd is leading manufacturers and exporter of agrochemicals, crop nutrients, Technicals & formulations. The Company caters to its distribution network that covers the domestic market and export to Asia, Africa, Latin America and Middle East.
The above news is from AgroPages